European Journal of Gynaecological Oncology
Print ISSN: 0392-2936 | Online ISSN: 2709-0086
European Journal of Gynaecological Oncology (EJGO) is an international, peer-reviewed, open access journal. EJGO publishes on a broad range of gynaecologic oncology topics. Different types of articles are considered for publication (see Aims & Scope) with emphasis on original research to include prospective clinical trials, basic and applied science, case-control, and cohort studies. We also encouraged the submission of systematic reviews and meta-analyses.
Articles
A review of robotic surgery in the management of recurrent ovarian carcinoma: indication and techniques
A review of robotic surgery in the management of recurrent ovarian carcinoma: indication and techniques
DOI: 10.22514/ejgo.2022.030
(This article belongs to the Special Issue Radical Surgery in Ovarian Cancer)
Phase III clinical trials of radical hysterectomy with minimal parametrectomy for patients with early-stage cervical cancer: a review
Phase III clinical trials of radical hysterectomy with minimal parametrectomy for patients with early-stage cervical cancer: a review
DOI: 10.22514/ejgo.2022.026
PTEN gene and AKT/mTOR pathway in gynecological cancers and cancer immune escape
PTEN gene and AKT/mTOR pathway in gynecological cancers and cancer immune escape
DOI: 10.22514/ejgo.2022.024
Review of neoadjuvant chemotherapy characteristics in advanced epithelial ovarian cancer: experience from two cancer centers
Review of neoadjuvant chemotherapy characteristics in advanced epithelial ovarian cancer: experience from two cancer centers
DOI: 10.22514/ejgo.2022.021
Preoperative imaging with positron emission tomography and computed tomography (18F-FDG PET/CT) or contrast-enhanced computed tomography (CECT) scan in operable cervical cancer: a prospective study
Preoperative imaging with positron emission tomography and computed tomography (18F-FDG PET/CT) or contrast-enhanced computed tomography (CECT) scan in operable cervical cancer: a prospective study
DOI: 10.22514/ejgo.2022.028
Early warning model of recurrence site for breast cancer rehabilitation patients based on adaptive mesh optimization XGBoost
Early warning model of recurrence site for breast cancer rehabilitation patients based on adaptive mesh optimization XGBoost
DOI: 10.22514/ejgo.2022.031
KRT17 enhances carboplatin resistance in ovarian cancer through the AKT/mTOR pathway
KRT17 enhances carboplatin resistance in ovarian cancer through the AKT/mTOR pathway
DOI: 10.22514/ejgo.2022.032
Clinical diagnostic and prognostic value of plasma Hsp90α in invasive breast cancer
Clinical diagnostic and prognostic value of plasma Hsp90α in invasive breast cancer
DOI: 10.22514/ejgo.2022.027
Knockdown of FAM83D inhibits endometrial cancer cell viability and induces autophagy via the PI3K/AKT/mTOR axis
Knockdown of FAM83D inhibits endometrial cancer cell viability and induces autophagy via the PI3K/AKT/mTOR axis
DOI: 10.22514/ejgo.2022.033
Clinical implications of overweight regarding response and survival in locally advanced cervical cancers treated with curative chemoradiation: a retrospective and multi-institutional research
Clinical implications of overweight regarding response and survival in locally advanced cervical cancers treated with curative chemoradiation: a retrospective and multi-institutional research
DOI: 10.22514/ejgo.2022.034
Knockdown of GALNT7 promotes cell apoptosis and autophagy of breast cancer cells by inactivation of STAT3
Knockdown of GALNT7 promotes cell apoptosis and autophagy of breast cancer cells by inactivation of STAT3
DOI: 10.22514/ejgo.2022.035
Vitexin exerts anti-tumor and anti-angiogensis effects on cervical cancer through VEGFA/VEGFR2 pathway
Vitexin exerts anti-tumor and anti-angiogensis effects on cervical cancer through VEGFA/VEGFR2 pathway
DOI: 10.22514/ejgo.2022.036
A rare case of pseudomyxoma peritonei caused by borderline mucinous tumor arising from primary mature cystic ovarian teratoma
A rare case of pseudomyxoma peritonei caused by borderline mucinous tumor arising from primary mature cystic ovarian teratoma
DOI: 10.22514/ejgo.2022.022
Vulvar granular cell tumour in a recently post-partum woman: a case report
Vulvar granular cell tumour in a recently post-partum woman: a case report
DOI: 10.22514/ejgo.2022.037
Dermal invasion matters in breast cancer sentinel lymph node biopsy results
Dermal invasion matters in breast cancer sentinel lymph node biopsy results
DOI: 10.22514/ejgo.2022.029
Published Ahead of Print
Estrogen receptor 1 and Aurora kinase A as potential diagnostic biomarkers for cervical cancer
Estrogen receptor 1 and Aurora kinase A as potential diagnostic biomarkers for cervical cancer
Online publish date: 11 July 2022
DOI: 10.22514/ejgo.2022.025
DNAJB5 (hsc40) gene as a novel biomarker for cervical cancer
DNAJB5 (hsc40) gene as a novel biomarker for cervical cancer
Online publish date: 07 July 2022
DOI: 10.22514/ejgo.2022.023
Special Issues
Topic Collection "Current Novel Treatment of Patients with Ovarian Cancer"
Keywords: Ovarian Cancer, Epithelial Ovarian Cancer, Optimal Debulking Surgery, Chemotherapy HIPEC, Platinum-resistant Ovarian Cancer, Anti-angiogenesis, PARP Inhibitors
Editor: Samir A. Farghaly, MD, PhD,Scott M. Eisenkop, MD
Submission deadline: 31 December 2022
Breast Cancer
Keywords: Breast cancer;Systemic treatment;Adjuvant setting;Metastatic setting;Genetic councelling;Triple negative breast cancer;Her2+ Breast cancer;Endocrine treatment
Editor: Michael Friedrich, MD,Nicolò Bertozzi, MD
Submission deadline: 30 April 2022
Systematic Review or Meta-Analysis in Gynaecological Oncology
Keywords: Cervical cancer;Ovarian cancer;Uterine/endometrial cancer;Vulvar cancer;Vaginal cancer;Breast cancer;Gestational trophoblastic disease;Primary peritoneal cancer
Editor: Enrique Hernandez, MD
Submission deadline: 25 April 2022
Advanced Decision Support Systems for Efficient Diagnosis of Gynaecological Cancers
Keywords: Computational and Mathematical Methods; Gynaecological Cancers; Machine Learning; Optimization Algorithms
Editor: Liaqat Ali, PhD
Submission deadline: 31 October 2022
Polycystic Ovary Syndrome and the Risk of Endometrial Cancer
Keywords: PCOS; Endometrial Hyperplasia; Endometrial Cancer; Unopposed Estrogen Effect; Progesterone Resistance; Endometrial Mesenchymal Stroma/Stem Cells; Obesity; Insulin Resistance; Hyperandrogenism; Inflammation
Editor: Masuma Khatun, PhD
Submission deadline: 24 June 2023
The management of endometrial cancer
Keywords: Endometrial Cancer; High-risk Factors; Adjuvant Treatment; Endocrine Therapy; Targeted Therapy
Editor: Nicolae Gica, MD, PhD,Yoland Antill, BMed FRACP MD
Submission deadline: 31 July 2023
Molecular Characterization in Endometrial Cancer: Progress and Prospects
Keywords: Endometrial Cancer (EC); Molecular Biomarkers; Immune Checkpoint Inhibitor; Precision Medicine
Editor: Andrea Giannini, MD, PhD
Submission deadline: 31 December 2022
Immunotherapy for Gynecological Oncology
Keywords: Cancer immunotherapy;Cancer vaccination;Immune checkpoint inhibitor;Ovarian cancer;Cervical cancer;Endometrial cancer
Editor: Tadahiro Shoji, MD
Submission deadline: 31 July 2021
Enhanced Recovery of Gynecological Oncology
Keywords: Gynecological Cancer; Enhanced Recovery After Surgery; Minimally Invasive Surgery; Pain Management; Nutritional Support; High Quality Nursing; Psychological Counseling; Complication Management
Editor: Lin Li, MD
Submission deadline: 31 December 2022
New Progress in Gynecological Tumor Surgery
Keywords: Gynecological Tumors; Minimally Invasive Surgery; Single Hole Laparoscopic Surgery; High-intensity Focusing Ultrasound(HIFU); Microwave Ablation (MWA)
Editor: Jiming Chen, MD,Bairong Xia, MD,Yisong Chen, MD
Submission deadline: 31 January 2023
Featured Article
Real-world bevacizumab utilization and outcomes among women with ovarian cancer in Europe and the United States. DOI: 10.31083/j.ejgo4206181
To Be a Reviewer
If you would like to volunteer to review a manuscript for European Journal of Gynaecological Oncology journal, please click “Review for EJGO” below to register at our submission website or log in our Online Peer Review system. Your name, contact details, and expertise will be automatically added to our database of reviewers.
Review for EJGOJoin Editorial Board
You are welcome to join our editorial board. Our journal produces and issues editorial board certificates for editorial board members, and the journal website will display the names and personal websites of editorial board members to help enhance their scientific influence. Members of the editorial committee are entitled to 1 free publication (both editorial member’s or recommended paper) per year, and other articles over 2 can enjoy 30% discount of publishing fee.
Join Editorial BoardEditor-in-Chief
Prof. Enrique Hernandez, MD, FACOG, FACS.
Dr. Hernandez is the J. Robert Willson Professor and Chair, Obstetrics, Gynecology and Reproductive Sciences of Lewis Katz School of Medicine at Temple University. He is also a professor in Pathology and Laboratory Medicine of Lewis Katz School of Medicine at Temple University. He specializes in comprehensive, compassionate care of women with gynecologic cancer and pre-cancerous conditions, using the most up-to-date and sophisticated diagnostic and treatment tools.